Role of extracellular signal-regulated kinase-1/2 (ERK) on complete remission achievement of primary adult acute lymphoblastic leukemia patients enrolled in the GIMEMA protocol LAL 2000: in vitro activity of the MEK inhibitor PD98059.
- Publication date
- 1 January 2005
- Publisher
